InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the full record of transactions filed by Susman Robert Graham, Director. Insider active across 1 company, notably Immunovant, Inc.. Aggregated, 3 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €58k. History available since 1 May 2025. The latest transaction was filed on 1 May 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Susman Robert Graham
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
2,502 股@ US$27.170.0010% mcap50.0% 占其流量Common StockSEC:0001764013-26-000058:0
13,880 股0Common StockSEC:0001764013-26-000042:0
25,016 股0Common StockSEC:0001415889-25-012045:0
3 条申报中的 3 条
About Susman Robert Graham
Robert Graham Susman is a Director at Immunovant, Inc. He brings his expertise in strategy and corporate governance to the board. Robert is involved in overseeing the company's performance and providing strategic direction for business initiatives. His experience in the pharmaceutical sector enables him to contribute effectively to discussions and decision-making at Immunovant.
